News: Orexigen Therapeutics Inc (OREX.OQ)
OREX.OQ on NASDAQ Stock Exchange Global Select Market
7.55USD
3:27pm EDT
7.55USD
3:27pm EDT
Price Change (% chg)
$0.01 (+0.13%)
$0.01 (+0.13%)
Prev Close
$7.54
$7.54
Open
$7.51
$7.51
Day's High
$7.66
$7.66
Day's Low
$7.46
$7.46
Volume
160,008
160,008
Avg. Vol
337,439
337,439
52-wk High
$7.84
$7.84
52-wk Low
$3.77
$3.77
Select another date:
Select another date:
Press Releases
- Orexigen Therapeutics Concludes Light Study Patient Screening, Expecting to Randomize Approximately 9,000 Patients, and Presents New Obesity Therapeutics Market Research
- Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
- David Endicott Joins Orexigen Therapeutics Board of Directors
- Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
- Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
- Orexigen Therapeutics Schedules November 7, 2012 Conference Call and Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2012
- Orexigen® Therapeutics Prices Public Offering of Common Stock
- Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock
- Orexigen Therapeutics Receives Dispute Response Indicating FDA is Highly Supportive of Exploration of a Faster Path to Resubmission of the Contrave NDA
- Orexigen Therapeutics to Host Conference Call and Webcast on Monday, October 22, 2012 to Provide a Company and Light Study Update

